Founded to transform patient care, Prime Medicine utilizes its versatile Prime Editing platform to correct approximately 90% of known disease-causing genetic mutations. This next-generation gene editing approach enables precise 'search and replace' functions within the genome, minimizing unwanted DNA modifications. Prime Medicine's diversified portfolio targets areas such as hematology, immunology, liver, lung, ocular, and neuromuscular diseases, aiming to provide long-lasting cures for patients worldwide.